Enzychem Lifesciences Corporation (KOSDAQ:A183490) announced a private placement of 79,373 preferred stock of par value KRW 500 per stock at a price of KRW 81,900 per stock for gross proceeds of KRW 6,500,648,700 on February 26, 2021. The company will issue securities through third party allotment. The transaction has been approved by the board of directors of the company. The transaction has a payment date of March 8, 2021. The securities issued in the transaction will be subject to a hold period of one year after issuance. The preferred stocks are convertible into 79,373 shares of the company during March 8, 2022 to March 7, 2026. Post completion of the transaction, the number of preferred shares will increase from 39,749 shares to 119,122 shares.